Skip to main content

Table 2 Association between individual MetS component and coronary parameters according to diabetes status

From: Differential association between metabolic syndrome and coronary artery disease evaluated with cardiac computed tomography according to the presence of diabetes in a symptomatic Korean population

Characteristic n Any plaque Obstructive plaque CACS >100
   OR (95% CI) OR (95% CI) OR (95% CI)
No diabetes 2308    
Obesity     
No 1383 1.00 1.00 1.00
Yes 925 1.27 (1.05–1.55) 1.20 (0.91–1.59) 1.19 (0.88–1.62)
Increased blood pressure     
No 664 1.00 1.00 1.00
Yes 1644 1.25 (1.01–1.55) 1.59 (1.14–2.23) 1.27 (0.89–1.81)
Increased triglycerides     
No 1522 1.00 1.00 1.00
Yes 786 1.37 (1.12–1.68) 1.56 (1.18–2.06) 1.18 (0.87–1.62)
Decreased HDL     
No 1616 1.00 1.00 1.00
Yes 692 1.35 (1.09–1.68) 1.55 (1.14–2.10) 1.57 (1.12–2.19)
Increased fasting glucose     
No 1640 1.00 1.00 1.00
Yes 668 1.22 (0.99–1.50) 0.97 (0.72–1.31) 1.24 (0.90–1.69)
Type 2 diabetes 561    
Obesity     
No 288 1.00 1.00 1.00
Yes 273 1.27 (0.85–1.90) 0.86 (0.57–1.31) 1.12 (0.72–1.75)
Increased blood pressure     
No 140 1.00 1.00 1.00
Yes 421 1.03 (0.65–1.63) 0.76 (0.48–1.21) 1.11 (0.66–1.86)
Increased triglycerides     
No 315 1.00 1.00 1.00
Yes 246 1.34 (0.89–2.02) 1.00 (0.65–1.53) 0.93 (0.59–1.47)
Decreased HDL     
No 347 1.00 1.00 1.00
Yes 214 0.92 (0.60–1.40) 1.44 (0.93–2.24) 1.13 (0.70–1.82)
  1. All models are adjusted for age, sex, current smoking, LDL, and GFR. CACS, coronary artery calcium score; CI, confidence intervals; GFR, glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein, MetS, metabolic syndrome; OR, odds ratios. *P <0.001; P <0.01; P <0.05.